DXRX
vs
207940
DXRX
207940
Over the past 12 months, DXRX has significantly outperformed Samsung Biologics Co Ltd, delivering a return of +43% compared to the Samsung Biologics Co Ltd's 0% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
DXRX
207940
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Multiples-Based Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
Diaceutics PLC
LSE:DXRX
|
161.5
GBX
|
|||||
|
Samsung Biologics Co Ltd
KRX:207940
|
999 999.9999
KRW
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
DXRX, 207940
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
Diaceutics PLC
Revenue
|
|||||||||||
|
Samsung Biologics Co Ltd
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
DXRX, 207940
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
Diaceutics PLC
LSE:DXRX
|
|||||||||
|
Samsung Biologics Co Ltd
KRX:207940
|
|||||||||
Compare company's free cash flow with its competitors.
Gross Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Diaceutics PLC | ||||
|
Samsung Biologics Co Ltd | ||||
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Diaceutics PLC | ||||
|
Samsung Biologics Co Ltd | ||||
Net Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Diaceutics PLC | ||||
|
Samsung Biologics Co Ltd | ||||
FCF Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Diaceutics PLC | ||||
|
Samsung Biologics Co Ltd | ||||
ROE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Diaceutics PLC | ||||
|
Samsung Biologics Co Ltd | ||||
ROA
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Diaceutics PLC | ||||
|
Samsung Biologics Co Ltd | ||||
ROIC
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Diaceutics PLC | ||||
|
Samsung Biologics Co Ltd | ||||
ROCE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Diaceutics PLC | ||||
|
Samsung Biologics Co Ltd | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
DXRX, 207940
Performance Gap
DXRX, 207940
Performance By Year
DXRX, 207940
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
|
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
|
| US |
|
Danaher Corp
NYSE:DHR
|
|
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
|
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
|
| CH |
|
Lonza Group AG
SIX:LONN
|
|
| US |
|
Agilent Technologies Inc
NYSE:A
|
|
| US |
|
Waters Corp
NYSE:WAT
|
|
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
|
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|